Synthesis of the Sulphonate and Phosphonate Derivatives of
Mercaptoacetyltriglycine. X-Ray Crystal Structure of Na2[ReO(Mercaptoacetylglycylglycylaminomethanesulphonate)]·3H2O by Hansen, Lory et al.
SYNTHESIS OF THE SULPHONATE AND PHOSPHONATE DERIVATIVES OF
MERCAPTOACETYLTRIGLYClNE. X-RAY CRYSTAL STRUCTURE OF
Na2[ReO(MERCAPTOACETYLGLYCYLGLYCYL-
AMINOMETHANESULPHONATE)]-3H20
Lory Hansen,* Andrew Taylor, Jr., and Luigi G. Marzilli
Departments of Chemistry and Radiology, Emory University, Atlanta, Georgia 30322, USA
Abstract
Mercaptoacetyltriglycine forms complexes with 186/188Re and 99mTc radionuclides that are useful
in nuclear medicine because they are substrates of the renal anion transport system. However,
the renal clearance of [MO(MAG3)]2- (MAG3 = penta-anionic form of mercaptoacetyltriglycine, M =
Re, Tc) complexes are less than ideal. Organic sulphonates are also transported by the renal
anion transport system and phosphonates are similar to sulphonates in size and shape. In an
effort to develop new ligands that form Re and Tc complexes and have improved renal clearances
compared to [MO(MAG3)]2- complexes, the sulphonate and phosphonate derivatives of
mercaptoacetyltriglycine were synthesized. The dianion [ReO(MAG2-AMS)]2- (MAG2-AMS =
penta-anionic form of mercaptoacetylglycylglycylaminomethanesulphonic acid) was prepared for
characterization by exchange reaction of ReOCI3(Me2S)(OPPh3) and isolated as the disodium
salt. The structure of Na2[ReO(MAG2-AMS)].3H20 () was determined by X-ray diffraction. The
coordination geometry is pseudo square pyramidal, with the nitrogen and sulfur donor atoms
forming a square base and the oxo ligand at the apex. The deprotonated sulphonate group has a
syn conformation with respect to the oxo ligand. The renal clearances of [99mTcO(MAG2-AMS)]2"
and [99mTcO(MAG2-AMP)]3" were similar in rats and suggest that the difference in total charge
between the SO3" and PO32" groups is not important to renal clearance. However, their renal
clearances were 40-50% less than that of [99mTcO(MAG3)]2" suggesting that the size and shape
of the large tetrahedral SO3" and PO32- groups of [99mTcO(MAG2-AMS)]2" and [99mTcO(MAG2-
AMP)]3" inhibit recognition by the renal transport system compared to the small planar CO2" group
of [99mTcO(MAG3)]2"
Introduction
Mercaptoacetyltriglycine (MAG3H5) forms complexes with Re and Tc that are substrates of
the renal transport system for organic anions. In fact, derivatives of [99mTcO(MAG3)]2" and
[186ReO(MAG3)]2" (MAG3 = penta-anionic form of MAG3H5) are being used to radiolabel
antibodies in investigational cancer diagnosis and therapy, in part because the radiolabeled
catabolites and metabolites are rapidly excreted by the kidneys.I,2 [99mTcO(MAG3)]2" is also
used in nuclear medicine to evaluate renal tubular function. However, the renal clearance of
[99mTcO(MAG3)]2" is only 50-60% that of radioiodinated [1311]-o-iodohippurate (OIH)3 which is
also used clinically to evaluate renal function. Since therapeutic applications for 186Re and 188Re
radiolabeled antibodies are under investigation and 99mTc is the preferred diagnostic radionuclide
in nuclear medicine procedures, it is important to develop new ligands that not only form Re and
Tc chelates but are also superior substrates for the renal anion transport system.
Organic sulphonates are also substrates for the renal anion transport system. A
sulphonate group is similar to a carboxylate group in that both are mono-anionic oxo acids at
physiological pH and both serve as the primary recognition site for renal tubular transport.
However, a sulphonate is a large tetrahedral group while a carboxylate is a smaller planar group.
The charge on a sulphonate group is also more diffuse than that of a carboxylate group because
the sulphonate has an additional oxo group participating in electron delocalization.
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Previously, Nosco and coworkers4 reported that the total clearance of [99mTcO(MAG2-
taurine)]2" (MAG2 = mercaptoacetylglycylglycyl) was slower than that of [99mTcO(MAG3)]2" in the
rat. (Renal clearance was not reported.) Hepatobiliary excretion was evidently significant with the
taurine analogue. However, the reasons for the differences in the biological properties o!
[gemTcO(MAG3)]2" and [99mTcO(MAG2-taudne)]2" were unclear because the tauryl residue in
[99mTcO(MAG2-taudne)]2" is a amino sulphonic acid. The renal clearance of [ggmTcO(MAG2-J-
alanine)] is also infedor to that of [99mTcO(MAG3)]2-.5
In an effort to determine the properties that best facilitate rapid renal transport, two
derivatives of MAG3H5 were synthesized. Mercaptoacetylglycylglycylaminomethanesulphonic
acid (MAG2-AMSH5) was designed to determine the effect of the differences between a
carboxylate and sulphonate group (size, shape and charge distribution) on renal clearance.
However, the presence of amine and sulphonic acid groups on the same carbon presented
synthetic problems which required a new synthetic a p p r o a c h.
Mercaptoacetylglycylglycylaminomethylphosphonic acid (MAG2-AMPI-16) was also synthesized to
determine if a difference in the formal charge of the anionic group had an effect on renal
clearance. The phosphonate group is similar to a sulphonate group in size and shape but it is
dianionic at physiological pH. Like MAG3H5, these ligands form [Tc(V)O]3+ and [Re(V)O]3+
complexes in which the mercapto and amide donor groups are deprotonated; the terminal anionic
groups are also fully deprotonated at physiological pH. Comparisons between [99mTcO(MAG2-
AMS)]2" (MAG2-AMS = penta-anionic form of MAG2-AMSH5), [99mTcO(MAG2-AMP)]3" (MAG2-
AMP = hexa-anionic form of MAG2-AMPH6) and [9ernTcO(MAG3)]2" are straightforward because in
all three complexes the terminal residues are <x-amino adds.
The renal dearances of the 99mTc complexes with the new ligands have been measured
in rats.6 The renal clearances of the sulphonate, [99mTcO(MAG2-AMS)]2", and phosphonate,
[99mTcO(MAG2-AMP)]3", complexes are comparable suggesting that for both complexes the
stereoelectronic interaction with the renal anion transport receptor is similar. A representative
Re(V) oxo complex was prepared with the sulphonate ligand for characterization and the solid-
state structure of Na2[ReO(MAG2-AMS)].3H20 was determined by X-ray diffraction methods.
The structure of [ReO(MAG2-AMS)]2" is important because the terminal anionic group (SO3")
(which is expected to be conformationally flexible in solution) is syn to the oxo ligand. A syn
conformation is generally believed to be important for efficient renal clearance since syn-
[99mTcO(map)]2-(map = penta-anionic form of 2,3-bis(mercaptoacetamido)propanoate) is
excreted at twice the rate of anti-[99mTcO(map)]2" 7 (The carboxylate groups of the
[99mTcO(map)]2" complexes are bound to chelate ring carbons and do not show conformational
flexibility.) Although [Ph4As][99TcO(MAG3H)] (MAG3H = tetra-anionic form of MAG3H5 in which
the carboxyl group is protonated) has a syn conformation in the solid-state the structural details
have not been reported.8 Others, [Bu4N][ReO(MAG3H)]9 and [Ph4P][ReO(MAG2-0ABAH)]10
(MAG2-ABAH = tetra-anionic form of mercaptoacetylglycylglycylaminobenzoic acid), adopt anti
conformations in the solid-state. Furthermore, the structure of [ReO(MAG2-AMS)]2" is unique in
that the terminal anionic group (SO3") is in its deprotonated, physiologically relevant from. All
other MO(N3S) and MO(N2S2) (M = Re, 99Tc) complexes for which crystal data are available have
protonated carboxyl groups. 8-11
Materials and Methods
NMR spectra were obtained at 300 MHz for 1H and 75 MHz for 13C with a General Electric
QE-300 spectrometer. The spectra were recorded in Me2SO-d6 or D20. Chemical shifts (ppm) in
Me2SO-d6 were referenced to the solvent peak 2.49 ppm (1H) and 39.9 ppm (13C) vs. TMS
(tetramethylsilane). Chemical shifts in D20 were referenced to dioxane 3.53 ppm (1H) and 66.5
ppm (13C) vs TMS. Elemental analyses were performed by Atlantic Microlabs Inc., Atlanta, GA.
FTIR spectra were recorded with a Bruker IFS 66 instrument. Yields are based on purified, air-
dded material.
Ligand Synthesis.
Phthaloylglycyl chloride12 (PGC) mp 83-85 C (lit. 83-85 C), succinimydyI-N-(S-
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benzoylthioacotato)13 (SBzMA-OSucc) 1H NMR (Me2SO-d6): 7.93 (d, 2H, SBzH), 7.69 (t, 1H,
SBzH,), 7.56 (t, 2H, SBzH), 3.89 (s, 2H, SCH2), and succinimidyI-N-(S-
benzoylthioacetyl)glycinate8 (SBzMAG-OSucc) 1H NMR (Me2SO-d6): 8.87 (t, 1H, CONH), 7.93
(d, 2H, SBzH), 7.71 (t, 1H, SBzH), 7.57 (t, 2H, SBzH), 4.30 (d, 2H, NCH2), 3.89 (s, 2H, SCH2),
2.80 (s, 4H, COCH2CH2CO) wore prepared by literature methods.
Gly(C)ylaminomethane=ulphoni(C) acid (1). Aminomethanesulphonic acid (15.3 g,
0.14 mol) and MgO (2.8 g, 0.07 mol) were suspended in H20 (300 ml) and cooled to 5 C. PGC
(15.7 g, 0.07 mol) in dioxane (75 ml) was added dropwiso to the aqueous suspension over 45
min. After the reaction mixture was stirred at room temperature for 1 h, it was brought to pH 1 with
concentrated HCI. The solvent was evaporated and the residue was crystallized from EtOH to
give phthaloylglycyl-aminomethanesulphonic acid (13.0 g, 0.04 mol) which was deprotected by
heating at reflux in alcoholic hydrazine (0.2 M, 300 ml) for 4 h. After cooling to room temperature,
the solid matedal was collected and dissolved in H20. The solution was filtered to remove any
remaining solid. Addition of acetone and allowing the solution to stand at 5C ovomight afforded
crystals. Yield: 4.4 g (38%). Anal. Cacld for C3H8N204S: C, 21.43; H, 4.80; N. 16.66. Found: C,
21.48; H, 4.79; N, 16.56. 1H NMR (Me2SO-d6):8.71 (t, 1H CONH), 7.94 (br, 3H, NH), 3.93 (d, 2H,
NCH2), 3.54 (s, 2H, SCH2).
Na[N-($-Benzoylthioa(C)etyl)gly(C)ylgly(C)ylaminomethane=ulphonate]
11:2H20 (:2). 1 (2.0 g, 0.01 reel) was dissolved in 80% MeOHIH20 (100 ml) by warming and
adjusting the pH to 7 with 1 N NaOH. SBzMAG-OSucc (4.0 g, 0.01 mol) was added to the solution
and the solution was heated at reflux for 2.5 h. The reaction mixture was loft at room temperature
ovomight. A white solid was collected and washed with hot CH3CN. Yield 2.5 g (50%). Anal.
Cacld for C14H17N3NaO7.5S: C, 38.71; H, 3.95; N, 9.67. Found: C, 38.70; H, 4.79; N, 9.69. 1H
NMR (Me2SO-d6): ppm 8.49 (t, 1H CONH), 8.22 (t, 1H CONH), 8.11 (t, 1H CONH), 7.93 (d, 2H,
SBzH), 7.70 t, 1H, SBzH), 7.56 (t, 2H, SBzH), 3.92 (d, 2H, NCH2), 3.87 (s, 2H, SCH2), 3.76
(overlapping d, 4H, NCH2). 13C NMR (Me2SO-d6): 190.57 (CO), 169.04 (CO), 168.49 (CO),
167.41 (CO), 136.41 (SBzC), 134.30 (SBzC), 129.38 (2C, SBzC), 127.12 (2C, SBzC), 55.50
(NCH2), 42.65 (NCH2), 42.08 (NCH2), 32.68 (SCH2).
Su(C)(C)inimidyI-N-(S-benzoylthioa(C)etyl)gly(C)ylgly(C)inate (3). SBzMA-OSucc (7.3
g, 25 mmol) was dissolved in warm EtOH (100 ml). Glycylglycine (3.3 g, 25 mmol) was dissolved in
H20 (30 ml) and the pH of the solution was brought to 7 with 1 N NaOH. The aqueous solution
was added to the alcoholic solution and heated at reflux for 2 h. The solution was left at room
temperature overnight. A white solid was collected and washed with MeOH. Yield 5.1 g (66%) for
N-(S-benzoylthioacetyl)glycylclycine (SBzMAG2). SBzMAG2 (5.0 g, 16 mmol) was dissolved in
THF (200 ml) along with N-hydroxysuccinimide (1.9 g, 16 mmol). The solution was cooled to 0 C.
Dicyclohexylcarbodiimide (4.1 g, 20 mmol) in THF (80 ml) and added dropwise over 30 min. The
reaction mixture was stirred for an additional 2 h at 0 C and then left at room temperature
overnight. Dicyclohexylurea was removed by filtration and the filtrate evaporated to dryness. The
residue was crystallized from ethyl acetate and iPrOH. Yield: 5.3 g (81%; 53% overall). Anal.
Cacld for C17H17N307S: C, 50.12; H, 4.21; N, 10.31. Found: C, 50.14; H, 4.25; N, 10.23. 1H
NMR (Me2SO-d6): 8.57 (t, 2H, CONH), 7.93 (d, 2H, SBzH), 7.70 (t, 1H, SBzH), 7.56 (t, 2H,
SBzH), 4.28 (d, 2H, NCH2), 3.88 (s, 2H, SCH2), 3.89 (d, 2H, NCH2), 2.80 (s, 4H,
C(O)CH2CH2CO).
Na[N-(S-Benzoy thIoa(C)etyI)gly(C)ylglycylaminomethylpho=phonate] .:2H20
(4). Aminomethylphosphonic acid (0.5 g, 4.5 retool) was dissolved in H20 (10 ml) and the pH of
the solution was brought to 7 with I N NaOH. SBzMAG2-OSucc (1.3 g, 3.2 mmol) in MeOH (20 ml)
was added and the reaction mixture was stirred at room temperature for 5 h. The solution was
filtered and acetone (100 ml) was added to the filtrate. The precipitate was collected and
dissolved in 67% MeOH/H20 (30 ml) and m-precipitated with acetone (100 ml). Yield 0.5 g (35%).
Anal. Cacld for C14H21NaN3OgPS: C, 36.45; H, 4.59; N, 9.11. Found: C, 36.41; H, 4.45; N,
9.47. 1H NMR (D20): 7.76 (d, 2H, SBzH), 7.50 (t, 1H, SBzH), 7.38 (t, 2H, SBzH), 3.81 (s, 2H,
CH2), 3.76 (s, 2H, CH2), 3.72 (s, 2H, CH2),3.19 (d, 2H, CH2P). 13C NMR (D20): 194.27 (CO),
171.82 (CO), 171.72 (CO), 170.61 (CO), 135.44 (SBzC), 134.62 (SBzC), 128.99 (2C, SBzC),
127.20 (2C, SBzC), 42.88 (NCH2), 42.36 (NCH2), 37.32 (d, J = 146 Hz, CH2P), 32.54 (SCH2).
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Synthesis of Rhenium(V) Complexes.
ReOCI:(Me2S)(OPPh) (5): This complex was prepared by the method of Grove
and Wilkinson.14a FTIR in KBr: 992 cm-I IRe=O], 1139 cm"I [P-O] (lit. 992 cm"I IRe--O], 1140
cm-1 [p.o]).14b
Na2[ReO(mercaptoacetyIglycylglycylaminomethanesu phonate)] -3H20
(6). 2 (0.37 g, 0.85 mmol) was dissolved in 63% MeOH/H20 (16 ml) and the pH of the solution
was brought to 8 with 1 N NaOH. 5 (0.55 g, 0.85 mmol) was added to the solution to give a green
suspension which was heated to 65-70 C. As the reaction proceeded, a pH of 8 was maintained
by dropwise addition of 1 N NaOH. The green suspension gradually cleared to give an orange
solution after I h. The solution was cooled to room temperature, filtered and extracted twice with
CHCI3. Ammonium hydroxide (5 ml) was added to the solution along with acetone (100 ml) and
the resulting solution left to stand at 5 C overnight. Orange microcrystals were collected and
washed with acetone. Yield 0.31 g (61%). X-ray quality crystals were obtained by slow diffusion of
EtOH into a saturated solution of the complex in H20. Anal. Cacld for C7H14Na2N3010ReS2: C,
14.10 H, 2.37; N, 7.04. Found: C, 14.23 H, 2.40; N, 7.03. 1H NMR (Me2SO-d6): 5.48, 4.39 (dd,
2H, J = 12 Hz, NCH2), 4.53 4.08 (dd, 2H, J = 18 Hz, NCH2), 4.13, 4.06 (dd, 2H, J : 18 Hz, NCH2),
3.75, 3.63 (dd, 2H0 J = 17 Hz, SCH2). 13(3 NMR: 192.43 (CO), 191.38 (CO), 188.58 (CO), 69.14
(NCH2), 56.18 (NCH2), 53.19 (NCH2), 38.76 (SCH2). FTIR in KBr: 972 cm"1 IRe=O].
X-ray Crystallography.
An orange pdsm of 6 having approximate dimensions of 0.26 x 0.42 x 0.58 mm was used
for data collection on a Siemens P4 diffractometer. The crystal system and cell dimensions were
determined by least-squares refinement of 30 centered reflections, 10 of which were > 24 in 20.
Two check refections were measured every 48 reflections and there was no significant deviation
in intensities. Intensities were corrected for Lorentz and monochromator polarization effects and
a semi-empirical absorption correction was applied based on azimuthal scans of 8 reflections.
Systematic absences were consistent with the unique space group Pbca. The structure was
solved by Patterson methods and all non-hydrogen atoms were refined anisotropically by full-
matrix least-squares procedures using SHELXTL PLUS (VMS). The water hydrogen atoms were
located from difference maps and the methylene hydrogen atoms were generated at calculated
(d(C-H) = 0.96 A) positions. The hydrogen atoms were constrained using a riding model with
isotmpic thermal parameters fixed at 0.08. Crystallographic data are summarized in Table I.
Results
The synthesis of S-benzoyl (SBz) protected [SBzMAG2-AMPH4]" (2) using a standard
activated ester coupling procedure10 was moderately successful (33% yield) at room
Table I. Crystallographic Data for. Na2[ReO(MAG2-AMS)].3H20 (6).
Chemical formula C7H14Na2N30loReS2
fw 596.5
space group Pbca
Z 8
a (A.) 18.039 (3)
b (.A) 9.774 (2)
c (A) 18.474 (3)
volume (A3) 3257.2 (10)
dcalcd (glcm3) 2.43
i(mm-1) 7.91 . 0.71073 A (Me Kcx
T(K) 298
min.lmax, transmission 0.0005 10.0066
R(%) 5.97
Rw (%) 6.96
floodqess-of:fit .1.86
temperature. Heating the reaction gave product that contained an impurity (by NMR) that was
difficult to remove. The synthesis of [SBzMAG2-AMSH3]" (4) was completely unsuccessful using
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the activated ester coupling procedure. (x-Amino sulphonic acids decompose to aldehyde, sulfur
dioxide and ammonia under acidic and alkaline conditions apparently because the free electron
pair on the nitrogen participates in the formation of an intermediate imine followed by loss of a
proton and hydrogen sulfite.15
NH2-CH(R)-SO3H --* NH--CH(R) + SO3H" + H+ --,,R-C + SO2 + NH3
Undoubtedly, the tendency of.(x-amino sulphonic acids to undergo such an electronic shift
reduces their nucleophilicity and the lack of any reactivily between aminomethanesulphonic acid
(AMS) and the relatively stable succinimidyl ester (SBzMAG2-OSucc) was unanticipated but not
surprising.
N-(carbobenzoxy)glycine and AMS were coupled using isobutylchloroformate by Frankel
and Moses16 in the late 1950’s (43% yield). However, removal of the protecting group by treating
with HBr to give glycylaminomethanesulphonic acid (1) resulted in an overall yield of 8%. In the
present study, phthaloylglycyl chlodde (PGC) and AMS were coupled based on the method of
Sheehan and Frank. 12 The phthaloyl protecting group was readily removed with hydrazine giving
1 in an overall yield of 38%. 1 was then coupled with SBzMAG-OSucc by the usual activated
ester procedure to give [SBzMAG2-AMSH3]’. Both [SBzMAG2-AMSH3]" and [SBzMAG2-
AMPH4]" were isolated as mono-sodium salts.
[SBzMAG2-AMSH3]" (=) reacted smoothly with ReOCI3(Me2S)(OPPh3) in aqueous
methanol resulting in a clear orange solution from which Na2[ReO(MAG2-AMS)] (6) was isolated.
The esence of a Re=O group was confirmed by a strong absorption in the FFIR spectrum at 972
cm.1.9-11 The coupling between geminal protons in the 1H NMR spectrum is consistent with a
square-pyramidal coordination environment.10 The 13C NMR signals are shifted significantly
downfield from the corresponding signals in the free ligand. Similar downfield shifts were
observed for the 13C NMR signals of the ortho, meta and para isomers of [ReO(MAG2-ABAH)]"
(MAG2-ABAH = tetra-anionic form of mercaptoacetylglycylglycylaminobenzoic acid). 10
[SBzMAG2-AMPH4]" (4) also reacted smoothly with ReOCI3(Me2S)(OPPh3)in aqueous
methanol resulting in a clear orange solution. However, the product could only be obtained in
poor yield as a crude oil. The FTIR spectrum in KBr of the crude product showed a strong band at
r 91 975 cm" character’stic of a Re=O st etch. The 1H NMR spectrum included signals similar to
those observed in the spectrum of Na2[ReO(MAG2-AMS)].3H20 (6) except that two of the signals
attributable to the geminal NC.HP protons were split into triplets due to coupling with each other
and phosphorus.
The structure of Na2[ReO(MAG2-AMS)].3H20 (6) was determined by X-ray diffraction. A
perspective drawing of the dianion of 6 is presented in Figure 1. Final atomic coordinates, are
listed in Table II and selected bond distances and ang!es are given in Table III. The coordination
geometry is square pyramidal with Re displaced 0.75 A out of the ligand coordination plane (S(1)0
N(1), N(2), N(3), mean deviation = 0.02 A) toward the apical oxo ligand. The Re bond distances
and angles are similar to those in the structures of other Re(V)O(N3S) species:
[Bu4N][ReO(MAG3H)],9 [Ph4P][ReO(MAG2-pABAH)]-H20,10 and [Ph4P][ReO(MAG2-
oABAH)]. 10
The sulphonate group in 6 is is deprotonated and adopts a syn conformation wt
respect to the oxo ligando Both the protonation state and the conformation of the terminal group
are important for the renal anion transport system because (1) the terminal group, in its anionic
form, serves as the primary recognition site for renal tubular transport and (2) the oxo ligand is
considered to be a secondary recognition site (at least in the related carboxylate species). 11,17
Since syn-[99rrrl’cO(map)]2" is excreted at twice the rate of ant/-[ggmTcO(map)]2" 7 simultaneous
recognition of the primary anionic group and the oxo ligand may be most effective when the
pdmary anionic and secondary (oxo) recognition sites are on the same side of the metal
coordination plane. 11 The structure of 6 is the first example of a Re(V)ON3S complex that
satisfies the charge and conformational cdteda for renal tubular transport in the solid-state. In the
reported crystal structures of other renal agents {[Bu4N][ReO(MAG3H)],9 [Ph4P][ReO(MAG2-
pABAH)].H20,10 [PPh4][ReO(MAG2.oABAH)],10 [Ph4As][99TcO(mapH)],11
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Figure 1. Perspective drawing of Na2[ReO(MAG2-AMS)].3H20 (dianion of 6) with 50%.
probability for the thermal ellipsoids.
Table II. Atomic Coordinates (xl04) and Equivalent Isotropic Displacement Coefficients (A2 x
1,03).,,for Na2[ReO(MAG2-AMS)].,3H20 (6).
atom x y z ,U(eq)
Re 8547(1) 1935(1) 4256(1) 52(1)
S(1) 7540(2) 710(3) 4629(2) 62(1)
S(2) 8499(2) -1090(3) 2779(2) 57(1)
N(1) 8400(6) 2876(10) 5212(6) 54(3)
N(2) 9595(6) 2322(12) 4567(6) 61(4)
N(3) 9087(5) 195(11) 3938(6) 56(3)
O(1) 8282(5) 2941(9) 3566(5) 67(3)
0(2) 7683(5) 3543(10) 6142(5) 63(3)
0(3) 10346(5) 3529(10) 5303(5) 67(3)
0(4) 10242(5) -717(10) 3719(6) 76(4)
0(5) 8154(5) -2419(10) 2674(5) 64(3)
O(6) 9160(5) -888(11) 2351(5) 73(3)
0(7) 7972(5) 18(8) 2700(5) 60(3)
C(1) 7194(7) 1835(13) 5329(8) 61(4)
c(2) 7772(8) 2845(14) 5588(7) 60(5)
C(3) 9026(7) 3689(16) 5458(7) 62(5)
C(4) 9733(8) 3185(13) 5106(7) 57(5)
c(5) 10176(8) 1506(17) 4228(8) 66(5)
C(6) 9851 (7) 263(16) 3929(7) 62(5)
C(7) 8756(7) -1084(13) 3716(7) 58(4)
Na(1) 6714(3) 307(6) 3024(3) 69(2)
Na(2) 8103(3) 2250(5) 2272(3) 64(2)
0(8) 6653(5) -512(9) 1804(5) 67(3)
0(9) 5489(5) 273(10) 3356(5) 74(3)
O(10) 9409(6) 2239(11) 2384(6) 82(4)
Equivalent isotropic U defined as one third of the trace of the orthogonalized Uij tensor
36L. Hansen, A. Taylor Jr. and L.G. Marzilli Metal Based Drugs
...Table II1.. Selected Bond Distances (/) and Angles (del) for Na[ReO(MAG2-AMS)].3H20 (6).
Bond distances (A)
Re-O(1) 1.680(9) Re-N(2) 2.011(10)
Re-S(1) 2.282(3) Re-N(3) 2.046(10)
Re-N(1) 2.009(10)
Bond angles (de<j)
S(1)-Re-O(1) 108.0(3) N(3)-Re-O(1) 113.8(4)
S(1)-Re-N(1) 82.5(3) Re-S(1)-C(1) 99.8(4)
S(1)-Re-N(2) 139.5(3) Re-N(1)-C(2) 124.1(9)
$(1)-Re-N(3) 91.7(3) Re-N(1)-C(3) 115.0(8)
N(1)-Re-N(2) 77.7(4) Re-N(2)-C(4) 120.7(9)
N(1)-Re-N(3) 134.1(4) Re-N(2)-C(5) 116.7(9)
N(2)-Re-N(3) 78.0(4) Re-N(3)-C(6) 116.0(9)
N(1)-Re-O(1) 111.2(4) Re-N(3)-C(7) 127.2(8)
.N(2)-Re-O(1) 112.015)
[Ph4P][99TcO(mapH)] 11 and [Ph4As][ReO(mapH)]}11 the terminal carboxyl groups are protonated
and the orientation of the carboxyl group is anti to the oxo ligand in [Bu4N][ReO(MAG3H)]9 and
[PPh4][ReO(MAG2-oABAH)]). 10 However, although the solid-state structure of 6 is in its
deprotonated, physiologically relevant form, the observed syn conformation could be due to
lattice interactions. Therefore, we examined possible interactions in the solid.
Within the crystal lattice there is an O(1), 0(5), 0(7), 0(8) bridging network (Figure 2) that
creates four Na+ channels with interatomic Na-Na distances of 3.3-3.4 A running parallel to the b
axis. Na(1) is surrounded in a pseudo-octahedral manner by S(1), 0(7), two water oxygen atoms
(0(8) and 0(9)), and two oxygen atoms from symmetry related dianions (O(la) symmetry position
(1.5-x, -0.5+y, z) and O(5a) symmetry position (1.5-x, 0.5+y, z)). Na(2) is also surrounded in a
pseudo-octahedral manner by O(1), 0(7), two water oxygen atoms (O(10) and O(8a) symmetry
S111
0(1) 0(80) 0(7)
0(101
Figure 2. Na+ coordination in the crystal lattice of Na2[ReO(MAG2-AMS)].3H20 (6).
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position (1.5-x, 0.5+y, z)), and two oxygen atoms from symmetry related dianions (O(2a) symmetry
position (x, 0.5-y, -0.5+z) and O(5a) symmetry position 1.5-x, 0.5+y, z)). Na(1) and Na(2) are
bridged by 0(7) and O(5a) with a Na-Na distance of 3.4 A. Na(1) is bridged to Na(2a) symmetry
position (1.5-x, -0.5+y, z) by O(1) and Na(2.) is bridged to Na(la) symmetry position (1.5-x, 0.5+y,
z) by 0(8) with Na-Na distances of 3.3 A. The syn conformation of the dianion is evidently
important in the solid state since Na(2) is coordinated by both O(1) and 0(7) and three out of the
four bridging oxygen atoms are sulphonate and oxo species.
Discussion
The predominant difference between [MO(MAG2-AMS)]2" and [MO(MAG3)]2- (M : Tc. Re)
appears to be the size and shape of the terminal anionic group (SO3" vs CO2") based on solid-
state models. The bond distances and angles associated with the metal coordination spheres of
Na2[ReO(MAG2-AMS)]-3H20 and [Bu4N][ReO(MAG3H)]9 are not significantly different and those
of [Ph4As][99TcO(MAG3H)]8 are comparable. Although them is a difference in the conformation
of the terminal anionic group of Na2[ReO(MAG2-AMS)]-3H20 (and [Ps][99TcO(MAG3H)]) and
[Bu4N][ReO(MAG3H), them is evidence that suggests the conformation is influenced by lattice
interactions involving coordination of both the oxo ligand (O(1)) and the sulphonate oxygen
atoms (0(5) and 0(7)) to the Na+ ions in an extended bridging network. Furthermore, these
complexes should be conformationally flexible in solution. [99mTcO(MAG2-AMS)]2" and
[ggmTcO(MAG2-AMP)]3" are also expected to be structurally similar since a phosphonate group is
similar in size and shape to a sulphonate group,.
The renal clearances (in rats) of [ggmTcO(MAG2-AMS)]2" and [99mTcO(MAG2-AMP)]3"
were approximately equal6 but showed a 40-50% decrease in renal clearance compared to
[99mTcO(MAG3)]2". These results suggest that the difference in total charge between the
sulphonate group and phosphonate group is not important for renal clearance. If the total charge
had been an important parameter, a significant difference in the clearance rates for
[99mTcO(MAG2-AMS)]2" and [99mTcO(MAG2-AMP)]3" would have been observed. However, the
similar decrease in the renal clearance of [99mTcO(MAG2-AMS)]2" and [ggmTcO(MAG2-AMP)]3"
compared to [99mTcO(MAG3)]2" suggest that the size and shape of a small planar CO2" group is
more easily recognized by the renal anion transport system than the larger tetrahedral SO3" and
PO32" groups.
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